Negative Pressure Wound Therapy Devices Market is expected to reach US$ 3.15 billion by 2030


PRESS RELEASE BY The Insight Partners 19 Mar 2024

Share this press on


Reusable NPWT Device Segment to Hold Significant Negative Pressure Wound Therapy Devices Market Share During 2022–2030

According to our latest study on "Negative Pressure Wound Therapy Devices Market Forecast to 2030 – Global Analysis – by Product, Wound Type, and End User," the market is expected to reach US$ 3.15 billion by 2030 from US$ 2.03 billion in 2022; it is anticipated to record a CAGR of 5.6% from 2022 to 2030. The report emphasizes the key factors driving the market and prominent players’ developments. Factors such as increase in the prevalence of diabetes and upsurge in government initiatives to increase awareness regarding diabetic foot ulcers are contributing to the growing negative pressure wound therapy devices market size. However, the high cost of negative pressure wound therapy devices restricts the market growth.

A sealed or foam dressing attached to a collection container to extract fluid from open wounds under controlled negative pressure. It is now a well-liked course of treatment for various acute and chronic wounds. By eliminating healing inhibitors, boosting blood flow, promoting angiogenesis and granulation tissue, and applying mechanical stress to the wound bed, NPWT facilitates wound healing. The technique is inappropriate for severe ischemia wounds. An occlusive dressing is placed over specialized wound packing using the NPWT method of wound management, and the dressing is vacuum-applied.

Negative Pressure Wound Therapy Devices Market, by Geography, 2022 (%)

Negative Pressure Wound Therapy Devices Market, by Geography, 2022 (%)


Negative Pressure Wound Therapy Devices Market Growth 2030

Download Free Sample

Negative Pressure Wound Therapy Devices Market Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Reusable NPWT Device and Single-Use NPWT Device), Wound Type (Diabetic Foot Ulcer, Pressure Ulcer, Venous Leg Ulcers, and Others), End User (Hospitals, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

Source: The Insight Partners Analysis

Moreover, NPWT accelerates final wound closure, shortens hospital stays, boosts granulation, increases local perfusion, and bolsters cell proliferation. In addition to being used for surgical or trauma wounds, NPWT is also frequently used for treating chronic wounds such as diabetic or pressure ulcers. The Agency for Healthcare Research and Quality (AHRQ) stated that over 2.5 million people in the US suffer from pressure ulcers annually. Thus, an increase in the prevalence of pressure ulcers drives the negative pressure wound therapy devices market growth.

The emergence of a novel range of wound care products presents prospects for enhancing accessibility to sophisticated therapies by expanding their applications and simplifying their administration. This would create lucrative opportunities for the market in the coming years.

Negative Pressure Wound Therapy Devices Market, by Product:

In terms of product, the market is divided into reusable NPWT devices and single-use NPWT devices. The reusable NPWT device segment held a larger negative pressure wound therapy devices market share in 2022 and is anticipated to record a CAGR of 5.8% during the forecast period. Reusable negative pressure wound therapy equipment is becoming increasingly popular due to its environmental friendliness and affordability. Reusable devices are a cost-effective option for healthcare providers and institutions looking to lower overall wound care costs. In addition, the rising preference for reusable and sterilizable devices over single-use ones is influenced by the growing emphasis on environmentally friendly practices in the healthcare industry.

Negative Pressure Wound Therapy Devices Market, by Wound Type:

By wound type, the negative pressure wound therapy devices market is segmented into diabetic foot ulcer, pressure ulcer, venous leg ulcers, and others. The pressure ulcer segment held the largest market share in 2022 and is anticipated to register the highest CAGR of 6.0% during the forecast period. In the US, over 2.5 million people suffer from pressure ulcers annually. These skin lesions cause discomfort, increase the chance of a serious infection, and require more medical attention. Increased morbidity and mortality as well as lengthier hospital stays are linked to pressure ulcers. Additionally, despite market and regulatory strategies to promote prevention and treatment, they continue to be a significant issue in nursing homes.

Negative Pressure Wound Therapy Devices Market, by Geography:

The market analysis is carried out by evaluating the market performance across different regions. The scope of the negative pressure wound therapy devices market report covers North America (the US, Canada, and Mexico), Europe (Spain, the UK, Germany, France, Italy, and the Rest of Europe), Asia Pacific (South Korea, China, India, Japan, Australia, and the Rest of Asia Pacific), the Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). North America has a sizable market for negative pressure wound therapy devices. Rising focus on effective wound management, increasing aging population, and upsurging incidence of chronic wounds propel the demand for advanced wound care solutions, including NPWT devices. Furthermore, the presence of key players and early adoption of technologically advanced products are likely to drive the region's negative pressure wound therapy devices market growth in the coming years. In February 2024, ExtriCARE USA, a pioneer in the Negative Pressure Wound Therapy (NPWT) sector, announced notable developments in both the ExtriCARE product line and the NPWT market. In August 2021, Aatru Medical, LLC announced the US Food and Drug Administration (FDA) 510(k) Class II clearance for the Negative Pressure Surgical Incision Management System (NPSIMS).

The negative pressure wound therapy devices market report emphasizes prominent players' developments. 3M; Smith+Nephew; DeRoyal Industries, Inc.; Nexa Medical Limited; Lion Street Medical, LLC (Pensar Medical LLC); ConvaTec Inc.; Cardinal Health, Inc.; Mölnlycke Health Care AB; PAUL HARTMANN; and Medela AG are among the prominent players operating in the market. Contributions and market initiatives of the key players such as Smith+Nephew and 3M positively influence the market growth.

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com

Download Free PDF Brochure